Bostwick D - Search Results

1

Overview consensus statement. Fifth International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer.

Garnick MB, Fair WR, Bostwick D, Debruyne F, Fourcroy J, Grignon D, Porterfield H, Sufrin G, Thrasher B, Hart C. Garnick MB, et al. Among authors: bostwick d. Mol Urol. 2000 Fall;4(3):89-92. Mol Urol. 2000. PMID: 11184767 Review. No abstract available.

2

Pathologic Handling and Reporting of Prostate Tissue Specimens in Patients Receiving Neoadjuvant Hormonal Therapy: Report of the Pathology Committee.

Grignon DJ, Bostwick DG, Civantos F, Garnick MB, Gaudin P, Srigley JR. Grignon DJ, et al. Mol Urol. 1999;3(3):193-198. Mol Urol. 1999. PMID: 10851323

3

ProstAsure Index in the detection of prostate cancer.

Burke HB, Bostwick DG. Burke HB, et al. Among authors: bostwick dg. Urology. 1998 Sep;52(3):531-2. Urology. 1998. PMID: 9730480 No abstract available.

4

Artificial neural networks improve the accuracy of cancer survival prediction.

Burke HB, Goodman PH, Rosen DB, Henson DE, Weinstein JN, Harrell FE Jr, Marks JR, Winchester DP, Bostwick DG. Burke HB, et al. Among authors: bostwick dg. Cancer. 1997 Feb 15;79(4):857-62. doi: 10.1002/(sici)1097-0142(19970215)79:4<857::aid-cncr24>3.0.co;2-y. Cancer. 1997. PMID: 9024725

5

Prediction of individual patient outcome in cancer: comparison of artificial neural networks and Kaplan--Meier methods.

Bostwick DG, Burke HB. Bostwick DG, et al. Cancer. 2001 Apr 15;91(8 Suppl):1643-6. doi: 10.1002/1097-0142(20010415)91:8+<1643::aid-cncr1177>3.0.co;2-i. Cancer. 2001. PMID: 11309762

6

Treatment of experimental bladder cancer with hyperthermia and phase transition liposomes containing methotrexate.

Bassett JB, Tacker JR, Anderson RU, Bostwick D. Bassett JB, et al. Among authors: bostwick d. J Urol. 1988 Mar;139(3):634-6. doi: 10.1016/s0022-5347(17)42548-1. J Urol. 1988. PMID: 3343756

7

What is the significance of race to prostate carcinoma?

Bostwick DG. Bostwick DG. Cancer. 1999 Sep 1;86(5):735-7. doi: 10.1002/(sici)1097-0142(19990901)86:5<735::aid-cncr1>3.0.co;2-r. Cancer. 1999. PMID: 10463964 No abstract available.

8

Scope of the problem. Indications for treatment and assessment of benign prostatic hyperplasia and its relationship to cancer.

Mebust W, Bostwick D, Grayhack J, Holtgrewe L, Wasson J, Kirby R, Mostofi K. Mebust W, et al. Among authors: bostwick d. Cancer. 1992 Jul 1;70(1 Suppl):369-70. doi: 10.1002/1097-0142(19920701)70:1+<369::aid-cncr2820701333>3.0.co;2-r. Cancer. 1992. PMID: 1376209 No abstract available.

9

Loss of chromosome arm 8p loci in prostate cancer: mapping by quantitative allelic imbalance.

MacGrogan D, Levy A, Bostwick D, Wagner M, Wells D, Bookstein R. MacGrogan D, et al. Among authors: bostwick d. Genes Chromosomes Cancer. 1994 Jul;10(3):151-9. doi: 10.1002/gcc.2870100302. Genes Chromosomes Cancer. 1994. PMID: 7522037

10

Progression of T1 bladder tumors: better staging or better biology?: reply.

Cheng L, Bostwick DG. Cheng L, et al. Cancer. 1999 Sep 15;86(6):910-2. doi: 10.1002/(sici)1097-0142(19990915)86:6<910::aid-cncr3>3.0.co;2-g. Cancer. 1999. PMID: 10491514 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

493 results

Search Page